• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

19
6
5
5
1

COUNTRY

1
1
1
1
1

CATEGORIES

  • 15
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1

PRICE

0
1
8
27

PUBLISHED

0
1
5
27

PRODUCT TYPE

27

Search "Injectable Antibodies. Products, Markets, Players and Forecasts" returned 27 results.

PRODUCT TITLE

Top 10 Drug Delivery Technologies (2010 - 2015)

STUDY GOALS AND OBJECTIVES: - To define and measure drug delivery market and its various sub-segments with respect to types of systems, by mode of drug delivery, by therapeutics and others - To identify...

February 2011
FROM
The Global Protein Therapeutics Market The Global Protein Therapeutics Market - Product Thumbnail Image

The Global Protein Therapeutics Market

The global protein therapeutics market was valued at US$57 billion in 2005 Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products presently...

December 2006
FROM
Delivering New Biopharmaceutical Therapies: Challenges & Opportunities Delivering New Biopharmaceutical Therapies: Challenges & Opportunities - Product Thumbnail Image

Delivering New Biopharmaceutical Therapies: Challenges & Opportunities

“Over the last decade, biotech antibodies have provided some of the biggest breakthroughs in medicine The list includes Avastin, Herceptin, Rituxan and Erbitux for cancer and Enbrel, Humira, and Remicade...

March 2009

Global Cancer Biomarkers Market (2010 - 2015)

Cancer is recognized as a major cause of mortality world over; accounting for 7 4 million (or 13%) of all deaths in 2004 The WHO estimates the incidence of cancer to continue rising to reach an estimated...

May 2010
FROM
Multi-therapy Drugs: Opportunities for Generics & Biosimilars Multi-therapy Drugs: Opportunities for Generics & Biosimilars - Product Thumbnail Image

Multi-therapy Drugs: Opportunities for Generics & Biosimilars

Highly-detailed analysis, outlook & forecasts of 24 leading drugs which are indicated for a range of critical conditions Targeting multiple conditions is likely to increase a drug's potential target...

October 2011
FROM
Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013 Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013 - Product Thumbnail Image

Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013

The market for injectable generics has been through a period of consolidation over the last few years as the leading companies have increased their presence through acquisition The major players include...

December 2013
FROM
Kidney Cancer Drugs - Global Business Strategic Report Kidney Cancer Drugs - Global Business Strategic Report - Product Thumbnail Image

Kidney Cancer Drugs - Global Business Strategic Report

This report analyzes the worldwide markets for Kidney Cancer Drugs in US$ Million. This report on Kidney Cancer Drugs provides market analytics specifically for the "Renal Cell Carcinoma" (RCC) market,...

May 2012
FROM
Drug Delivery Technology - Revolutionizing Cancer Therapies Drug Delivery Technology - Revolutionizing Cancer Therapies - Product Thumbnail Image

Drug Delivery Technology - Revolutionizing Cancer Therapies

"One of the biggest issues with current cancer therapies is that whilst most therapies procure quality of life they kill both healthy and tumor cells This offers drug delivery specialists a challenge...

April 2007
FROM
Anti-Infectives - Global Strategic Business Report Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

This report analyzes the worldwide markets for Anti-Infectives in US$ Million The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World Annual forecasts are provided...

February 2010
FROM
Advanced Oral & Parenteral Drug Delivery Technologies: Players, Products & Prospects to 2015 Advanced Oral & Parenteral Drug Delivery Technologies: Players, Products & Prospects to 2015 - Product Thumbnail Image

Advanced Oral & Parenteral Drug Delivery Technologies: Players, Products & Prospects to 2015

- A comprehensive examination of trends and advances in the two major drug delivery sectors - Unique sales forecasts to 2015 for key technology areas - Critical analyses of specialist developers driving...

January 2011
FROM

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

December 2010
FROM

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020” The report is an essential...

December 2010
FROM

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020” is an essential source...

December 2010
FROM

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020” is an essential source...

December 2010
FROM
Organ and Tissue Transplantation - Global Strategic Business Report Organ and Tissue Transplantation - Global Strategic Business Report - Product Thumbnail Image

Organ and Tissue Transplantation - Global Strategic Business Report

This report analyzes the worldwide markets for Organ and Tissue Transplantation by Number of Procedures The global and other markets (except the US) are analyzed only by Organ Type - Heart, Kidneys,...

February 2012
FROM

Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010 Summary Our pharmaceutical report, “Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010”...

November 2010
FROM
The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition - Product Thumbnail Image

The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition

The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition provides the most comprehensive report on the economic impact of nanotechnologies the author has released to date The report contains over...

June 2008

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020” The report is an...

November 2010
FROM

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis...

December 2010
FROM

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020

Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020 Summary Our pharmaceutical report, “Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020” is an essential source of information...

November 2010
FROM
Loading Indicator